首页|Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder

Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder

扫码查看
Background: Conventional drug treatments for Generalized Anxiety Disorder (GAD) are often accompanied by substantial side effects, dependence, and/or withdrawal syndrome. A prior controlled study of oral chamomile (Matricaria chamomilla L.) extract showed significant efficacy versus placebo, and suggested that chamomile may have anxiolytic activity for individuals with GAD.

ChamomileGeneralized anxiety disorderAnxiolyticHerbalBotanicalAlternative and complementary medicine

Keefe, John R.、Mao, Jun J.、Soeller, Irene、Li, Qing S.、Amsterdam, Jay D.

展开 >

Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA

Mem Sloan Kettering Canc Ctr, Bendheim Ctr Integrat Med, 1429 First Ave, New York, NY 10021 USA

Univ Penn, Perelman Sch Med, Dept Family Med & Community Hlth, Philadelphia, PA 19104 USA

Univ Penn, Dept Psychiat, Perelman Sch Med, Depress Res Unit, Philadelphia, PA 19104 USA

展开 >

2016

Phytomedicine

Phytomedicine

SCI
ISSN:0944-7113
年,卷(期):2016.23(14)
  • 15
  • 65